NCT00042562View on ClinicalTrials.gov

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

duloxetine

Trial Locations (23)

Unknown

Carlsbad

Los Angeles

Stanford

Cromwell

Coral Springs

Gainesville

Miami

Atlanta

Bangor

Boston

New York

Rochester

Cincinnati

Philadelphia

Pittsburgh

Dallas

Houston

San Antonio

Charlottesville

Falls Church

Richmond

Seattle

West Allis

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00042562 - Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression | Biotech Hunter | Biotech Hunter